Core Viewpoint - The Gross Law Firm is notifying shareholders of Xiao-I Corporation (NASDAQ: AIXI) about a class action lawsuit due to alleged misleading statements and non-compliance with financial regulations during the class period from March 9, 2023, to July 12, 2024 [1][2]. Group 1: Allegations Against Xiao-I Corporation - The complaint alleges that Xiao-I downplayed the risks associated with non-compliance from certain Chinese shareholders, affecting the company's ability to utilize offering proceeds for intended business purposes [2]. - Xiao-I is accused of failing to comply with Generally Accepted Accounting Principles (GAAP) in its financial statements [2]. - The company allegedly overstated its efforts to address material weaknesses in financial controls and exaggerated its AI capabilities and R&D resources [2]. - Significant R&D expenses incurred by Xiao-I to compete in the AI industry were downplayed, which negatively impacted the company's financial results [2]. - There is a substantial likelihood that Xiao-I would fail to meet NASDAQ's Minimum Bid Price Requirement due to these issues [2]. Group 2: Class Action Details - Shareholders who purchased AIXI shares during the specified class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for December 16, 2024 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. - Participation in the case incurs no cost or obligation for the shareholders [3].

Core Viewpoint - A class action securities lawsuit has been filed against Xiao-I Corporation, alleging securities fraud that affected investors between March 9, 2023, and July 12, 2024 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that defendants downplayed the risks Xiao-I faced due to non-compliance by certain Chinese shareholders, affecting the company's ability to use offering proceeds for intended business purposes [2]. - It is alleged that Xiao-I failed to comply with Generally Accepted Accounting Principles in its financial statements [2]. - The complaint states that defendants overstated Xiao-I's efforts to address material weaknesses in financial controls [2]. - Significant R&D expenses incurred by Xiao-I to compete in the AI industry were downplayed, impacting the company's financial results [2]. - The lawsuit asserts that Xiao-I overstated its AI capabilities and overall ability to compete in the market [2]. - There is a claim that Xiao-I may fail to comply with NASDAQ's Minimum Bid Price Requirement due to these issues [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified time frame have until December 16, 2024, to request appointment as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Xiao-I Corporation's American depository shares (ADSs) during the IPO and the subsequent class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased Xiao-I ADSs during the IPO or between March 9, 2023, and July 12, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 16, 2024 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including the largest settlement against a Chinese company at the time [4]. Group 3: Case Allegations - The lawsuit alleges that Xiao-I Corporation made false or misleading statements regarding its financial health and compliance with regulations, including the failure to disclose risks related to its Chinese shareholders' non-compliance with Circular 37 Registration [5]. - Specific allegations include overstating AI capabilities, R&D resources, and the potential to meet NASDAQ's listing requirements, which may have led to investor damages when the true information became public [5].

Core Viewpoint - Xiao-I Corp. is facing a class action lawsuit due to alleged misleading statements and non-compliance with NASDAQ's minimum bid price requirement, impacting investor confidence and stock performance [3][4]. Group 1: Class Action Details - The class action represents investors who purchased securities between March 9, 2023, and July 12, 2024, with a deadline of December 16, 2024, to file a lead plaintiff motion [1]. - The lawsuit was triggered by a notification from NASDAQ on July 11, 2024, indicating that Xiao-I was not in compliance with listing requirements [3]. Group 2: Allegations Against Xiao-I - The complaint alleges that the Offering Documents contained false statements and omitted necessary information, failing to comply with applicable regulations [4]. - Specific claims include the minimization of risks related to certain Chinese shareholders' non-compliance, non-GAAP compliant financial statements, and exaggerated efforts to address financial control weaknesses [4]. - The lawsuit also highlights significant R&D expenses incurred by Xiao-I to compete in the AI industry, which were downplayed in public statements, leading to an overstatement of the company's capabilities [4]. Group 3: Market Impact - Following the announcement of the NASDAQ notification, Xiao-I's American Depositary Shares (ADS) price fell by 2.28%, closing at approximately $0.67 per ADS on July 15, 2024 [4].

NEW YORK, Dec. 2, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Xiao-I Corporation (NASDAQ: AIXI): (i) American depository shares ("ADSs") pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about March 9, 2023 (the "IPO" or "Offering"); and/or (ii) securities between March 9, 2023 and July 12, 2024, both dates inclusive (the "Class Period"), of the important December 16, 2024 ...

NEW YORK, Nov. 29, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Xiao-I Corporation (NASDAQ: AIXI): (i) American depository shares (“ADSs”) pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about March 9, 2023 (the "IPO" or "Offering"); and/or (ii) securities between March 9, 2023 and July 12, 2024, both dates inclusive (the “Class Period”), of the important December 16 ...

SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Robbins LLP reminds shareholders that a class action was filed on behalf of all investors and entities that purchased or otherwise acquired Xiao-I Corporation (NASDAQ: AIXI) ADSs pursuant and/or traceable to the Company's initial public offering ("IPO") on March 9, 2023, or between March 9, 2023 and July 12, 2024. Xiao-I conducts business through its subsidiary Shanghai Xiao-I Robot Technology Co., Ltd., which comprises the Company's AI business.For more information, ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Xiao-I Corporation (NASDAQ: AIXI). Shareholders who purchased shares of AIXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/xiao-i-corporation-loss-submission-form/?id=113433&from=3 CLASS PERIOD: March 9 ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Xiao-I Corporation due to alleged violations of federal securities laws, encouraging affected investors to come forward [2][4]. Group 1: Company Overview - Xiao-I Corporation, listed on NASDAQ under the ticker AIXI, launched its initial public offering (IPO) on March 8, 2023, selling 5.7 million American depositary shares (ADSs) at $6.80 each [5]. - The company's ADS price has significantly dropped since the IPO, leading to substantial losses for investors [5]. Group 2: Allegations and Legal Actions - The complaint against Xiao-I alleges that the company and its executives made false or misleading statements regarding various operational and financial aspects, including risks related to Chinese shareholders' non-compliance and financial reporting standards [4]. - Specific allegations include overstating AI capabilities, R&D resources, and the company's ability to compete in the AI market, as well as failing to comply with GAAP in financial statements [4]. - Xiao-I received a notification from NASDAQ on July 11, 2024, indicating non-compliance with the minimum bid price requirement, as the closing bid price per ADS had been below $1.00 for 30 consecutive business days [7]. Group 3: Investor Information - Investors who suffered losses exceeding $50,000 due to their investment in Xiao-I are encouraged to contact Faruqi & Faruqi for discussions regarding their legal rights [1]. - The deadline for investors to seek the role of lead plaintiff in the federal securities class action against Xiao-I is December 16, 2024 [2].

NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Xiao-I Corporation (NASDAQ: AIXI).Shareholders who purchased shares of AIXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/xiao-i-corporation-loss-submission-form/?id=112800&from=4CLASS PERIOD: March 9, 2023 t ...